Munar Pharma

Munar Pharma FCF Conversion

Delisted

The FCF Conversion Rate (FCF/EBITDA) of Munar Pharma (MUN.WA) as of Nov 20, 2026 is -982.51 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -1.69 % — a change of 58,091.99% (lower).

FCF Conversion

-982.51 %

YoY

58,091.99%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Munar Pharma is 2024 -982.51 % . FCF Conversion Rate (FCF/EBITDA) of Munar Pharma was 2023 -1.69 % . It decreases by 58,091.99% lower compared to the previous year.

The Munar Pharma FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2017
213.11 PLN
Jan 1, 2018
23.94 PLN
Jan 1, 2019
-10,376.61 PLN
Jan 1, 2020
46.05 PLN
Jan 1, 2021
163.51 PLN
Jan 1, 2022
117.67 PLN
Jan 1, 2023
-1.69 PLN
Jan 1, 2024
-982.51 PLN
The Munar Pharma FCF Conversion history
YEARFCF ConversionYoY
-982.51 %+58,091.99%
-1.69 %-101.43%
117.67 %-28.04%
163.51 %+255.06%
46.05 %-100.44%
-10,376.61 %-43,450.82%
23.94 %-88.77%
213.11 %-426.10%
-65.35 %+2,523.10%
-2.49 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Munar Pharma Stock analysis

What does Munar Pharma do? No Gravity Games SA generates revenue by providing internet-related services, including content management systems, web shops, and website implementation. The company leverages its own technical infrastructure and programming resources to create and maintain specialized websites for its corporate clients. These digital assets include audiostereo.pl for audio enthusiasts, zagraj.com.pl as an online games portal, and legalneinfo.pl, which serves as an online catalogue of free software. The firm further supports application development and external software development for its corporate clients. Its portfolio extends to sport1.pl, offering information on disciplines such as football, volleyball, basketball, tennis, handball, and winter sports. Additional sites managed by the company include YOYO.pl, an independent provider of free hosting services, as well as chillisport.pl, oboe.pl, legenhit.pl, webtips.pl, xt.pl, and websonda.pl. Munar Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Munar Pharma stock

FCF Conversion Rate (FCF/EBITDA) of Munar Pharma is -982.51 % in 2024.

FCF Conversion Rate (FCF/EBITDA) of Munar Pharma changed from -1.69 % to -982.51 %, representing a 58,091.99% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Munar Pharma since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Munar Pharma with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Munar Pharma

All Key Metrics — Munar Pharma